BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6994118)

  • 21. The activation of murine B cells: the role of surface immunoglobulins.
    Vitetta E; Puré E; Isakson P; Buck L; Uhr J
    Immunol Rev; 1980; 52():211-31. PubMed ID: 6790419
    [No Abstract]   [Full Text] [Related]  

  • 22. Surface and functional characteristics of B cells from lupus-prone murine strains.
    Theofilopoulos AN; Balderas RS; Gozes Y; Fidler JM; Liu FT; Ahmed A; Dixon FJ
    Clin Immunol Immunopathol; 1982 May; 23(2):224-44. PubMed ID: 6980753
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo activation of naive T cells by antigen-presenting B cells.
    Morris SC; Lees A; Finkelman FD
    J Immunol; 1994 Apr; 152(8):3777-85. PubMed ID: 8144947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgD as a receptor in signaling the proliferation of mouse B-lymphocytes.
    Sieckmann DG; Finkelman FD; Scher I
    Ann N Y Acad Sci; 1982; 399():277-89. PubMed ID: 6984610
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
    Kelly K; Knox KA
    Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
    Gaur A; Yao XR; Scott DW
    J Immunol; 1993 Mar; 150(5):1663-9. PubMed ID: 8436810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane IgD expression and dynamics in clones of human B-lymphoblastoid cells.
    Roth P; Tonda P; Pernis B
    Ann N Y Acad Sci; 1982; 399():175-83. PubMed ID: 6299157
    [No Abstract]   [Full Text] [Related]  

  • 28. B-cell function in mice treated with anti-IgD from birth.
    Metcalf ES; Mond JJ; Scher I; LaVeck MA; Finkelman FD
    Ann N Y Acad Sci; 1982; 399():351-9. PubMed ID: 6984618
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting antigen to CD19 on B cells efficiently activates T cells.
    Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
    Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgD can largely substitute for loss of IgM function in B cells.
    Lutz C; Ledermann B; Kosco-Vilbois MH; Ochsenbein AF; Zinkernagel RM; Köhler G; Brombacher F
    Nature; 1998 Jun; 393(6687):797-801. PubMed ID: 9655395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of B-cell immune tolerance induction using transgenic mice.
    Ferry H; Cornall RJ
    Methods Mol Biol; 2004; 271():239-60. PubMed ID: 15146125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological subsets in human B-cell lymphomas.
    Godal T; Lindmo T; Marton PF; Landaas TO; Langholm R; Høie J; Foss Abrahamsen A
    Scand J Immunol; 1981 Nov; 14(5):481-92. PubMed ID: 6977823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface IgD as a functional receptor on murine B-lymphocytes.
    Zitron IM
    Ann N Y Acad Sci; 1982; 399():265-76. PubMed ID: 6984609
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced capture of extramembranous IgM and IgG on B cells in the NOD mouse--implications for immune complex trapping.
    Ekici R; Sundström M; Thay B; Lejon K
    Int Immunol; 2009 May; 21(5):533-41. PubMed ID: 19299625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.
    Ota T; Aoki-Ota M; Tsunoda K; Nishikawa T; Koyasu S; Amagai M
    Int Immunol; 2008 Oct; 20(10):1351-60. PubMed ID: 18765425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
    Lee JR; Koretzky GA
    J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
    Scher I; Berning AK; Kessler S; Finkelman FD
    J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do small B cells induce tolerance?
    Eynon EE; Parker DC
    Transplant Proc; 1991 Feb; 23(1 Pt 1):729-30. PubMed ID: 1990666
    [No Abstract]   [Full Text] [Related]  

  • 40. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.